Terkko Navigator / Aalto, K(ristiina) (PRC)*

A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella

Abdominal pain in Finnish young adults with juvenile idiopathic arthritis

Short interruptions of TNF-inhibitor treatment can be associated with treatment failure in patients with immune-mediated diseases

Transition to adult care in Finnish adolescents with juvenile idiopathic arthritis

Changing patterns in treatment, remission status and categories in a long-term Nordic cohort study of juvenile idiopathic arthritis

Bridge study protocol: an international, observational cohort study on the transition of healthcare for adolescents with chronic conditions

Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort

Uveitis in Juvenile Idiopathic Arthritis: 18-Year Outcome in the Population-based Nordic Cohort Study

Initiating disease-modifying anti-rheumatic drugs rapidly reduces purchases of analgesic drugs in juvenile idiopathic arthritis

Health-related quality of life during early aggressive treatment in patients with polyarticular juvenile idiopathic arthritis: results from randomized controlled trial

Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis: part 1-results of the Canadian model in the Nordic cohort

Longterm Outcomes of Temporomandibular Joints in Juvenile Idiopathic Arthritis: 17 Years of Followup of a Nordic Juvenile Idiopathic Arthritis Cohort

Complement lectin pathway protein levels reflect disease activity in juvenile idiopathic arthritis: a longitudinal study of the Nordic JIA cohort

Defining new clinically derived criteria for high disease activity in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study

Efficacy and safety of tocilizumab in a real-life observational cohort of patients with polyarticular juvenile idiopathic arthritis

Participation in school and physical education in juvenile idiopathic arthritis in a Nordic long-term cohort study

Pain interference and associated factors in young adults with juvenile idiopathic arthritis

Validating 10-joint juvenile arthritis disease activity score cut-offs for disease activity levels in non-systemic juvenile idiopathic arthritis

Long-Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis Cohort

Disability and health-related quality of life are associated with restricted social participation in young adults with juvenile idiopathic arthritis

Early Self-Reported Pain in Juvenile Idiopathic Arthritis as Related to Long-Term Outcomes: Results From the Nordic Juvenile Idiopathic Arthritis Cohort Study

Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study

The Finnish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)

Cryopyrin-associated periodic syndrome in early childhood can be successfully treated with interleukin-1 blockades

Anti-adalimumab antibodies in juvenile idiopathic arthritis-related uveitis

Incidence and predictors of Uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study

Psoriasis and associated variables in classification and outcome of juvenile idiopathic arthritis - an eight-year follow-up study

Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use

Genome-wide Association Study Identifies 27 Loci Influencing Concentrations of Circulating Cytokines and Growth Factors

Deregulation of ocular nucleotide homeostasis in patients with diabetic retinopathy

Effects of hormonal contraception on systemic metabolism: cross-sectional and longitudinal evidence

The Biomarker GlycA Is Associated with Chronic Inflammation and Predicts Long-Term Risk of Severe Infection

Special features of biological drug therapy in children

Finding specific 10-joint Juvenile Arthritis Disease Activity Score (JADAS10) and clinical JADAS10 cut-off values for disease activity levels in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study

Body composition and adipokines in patients with juvenile idiopathic arthritis and systemic glucocorticoids

Ankle arthritis predicts polyarticular disease course and unfavourable outcome in children with juvenile idiopathic arthritis

Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis

Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis

Still's disease--juvenile arthritis with systemic onset

Early prediction of persistent organ failure by soluble CD73 in patients with acute pancreatitis*

Distribution and medical impact of loss-of-function variants in the Finnish founder population

Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA)

Soluble vascular adhesion protein-1 predicts incident major adverse cardiovascular events and improves reclassification in a finnish prospective cohort study

Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis

HLA-B27 predicts a more chronic disease course in an 8-year followup cohort of patients with juvenile idiopathic arthritis

Prevention of infusion reactions to infliximab in paediatric patients with oral acetylsalicylic acid

Medical treatment of juvenile idiopathic arthritis

Validity and predictive ability of the juvenile arthritis disease activity score based on CRP versus ESR in a Nordic population-based setting

Soluble vascular adhesion protein-1 correlates with cardiovascular risk factors and early atherosclerotic manifestations

Clindamycin vs. first-generation cephalosporins for acute osteoarticular infections of childhood--a prospective quasi-randomized controlled trial